Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05872594
Other study ID # 0000640001
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 30, 2022
Est. completion date March 30, 2024

Study information

Verified date May 2023
Source I.M. Sechenov First Moscow State Medical University
Contact Polina Pchelina, PhD
Phone +79036701725
Email polbox@mail.ru, pchelina_p_v@staff.sechenov.ru
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A single-center, cross-sectional, non-interventional study based on the sleep department of the Kozhevnikov Clinic for Nervous Diseases at Sechenov University. A.Y. Kozhevnikov Sechenov University is being conducted between September 2022 and December 2023 to assess the prevalence and associated symptoms and risk factors of a multiple dreams with vivid emotion, causing morning and daytime symptoms - phenomenon of Epic Dream Disorder (EDD). Demographic, sleep and psychological characteristics of people with multiple dreams will be identified, including the following standardized scales: Spielberger Anxiety Scale, Beck Depression Scale, Shortened Sleep Questionnaire. Data will be collected by mean of online questionnaire tool. According to the data obtained, prevalence of the phenomenon, differences between continuous, rank and categorical variables will be calculated in participants with and without EDD. Multivariate logistic regression will be performed to assess associated risk factors of EDD.


Description:

In clinical practice, there are patients complaining for numerous dreams, which negatively affect the daytime well-being of patients, although these complaints do not fall into the category of nightmares. There are currently no data on the prevalence of the phenomenon of this phenomenon. Studies conducted on small groups of patients have found that they are more likely to have chronic pain syndrome, family history of their complaints. The proposed study will be able to provide the first data on the prevalence and concomitant symptoms of multiple dreams. This will allow the authors to give a more precise definition of this phenomenon, describe its concomitant symptoms, and evaluate the relevance of its diagnosis and treatment. The results of the study will set the stage for further clinical research on the pathogenesis and therapy approaches. The further studies are needed to explain the causes of this phenomenon to the patients and provide them with the necessary assistance. In view of the high workload of the medical staff, and clinical centers under the COVID-19 pandemic, and in order to increase convenience for both study participants and the researchers, data for this study will be collected remotely. The implementation of the study objectives did not require a face-to-face examination of the participants. Internet-based data collection will further simplify the processing of the data. This approach to conducting the study has already shown its applicability in a number of clinical trials. The study will be conducted at the I.M. Sechenov First Moscow State Medical University, Russian Ministry of Health, UTH No. 3, Clinic of Nervous Diseases. A.Y. Kozhevnikov, Department of Sleep Medicine. This study plans to inсlude all participants who agreed to participate (i.e., who clicked on the button "agree" after reading informed consent form). Information about the study and link to the questionnaires and informed consent form will be spreaded in social media, student communities, and university departmental staff communities The demographic, sleep, and psychological characteristics of people with multiple dreams will be assessed. Then a statistical analysis will be performed to compare the differences in rank, continuous, and categorical variables, and perform a multivariate logistic regression.


Recruitment information / eligibility

Status Recruiting
Enrollment 1000
Est. completion date March 30, 2024
Est. primary completion date December 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - consent to participate in the study, expressed by ticking the appropriate box on the website after reading the text of the informed consent, confirming their understanding of the study and their consent to participate in it; Exclusion Criteria: - age < 18 years; This criterion is evaluated when completing the questionnaire, questionnaires from participants under 18 years old will not be included in the statistical analysis

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Online questionnaire
data will be collected remotely on the online platform Qualtrics

Locations

Country Name City State
Russian Federation II.M. Sechenov First Moscow State Medical University (Sechenov University) Moscow

Sponsors (1)

Lead Sponsor Collaborator
I.M. Sechenov First Moscow State Medical University

Country where clinical trial is conducted

Russian Federation, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of the phenomenon of epic dream disorder prevalence of the disease - the proportion of participants with the diagnosed epic dream disorder to the whole sample Through study completion, an average of 1 year
Secondary Demographic outcomes: Sex options (male, female) Through study completion, an average of 1 year
Secondary Demographic outcomes: Age Age in years Through study completion, an average of 1 year
Secondary Demographic outcomes: Weight Weight in kg Through study completion, an average of 1 year
Secondary Demographic outcomes: Height Height in cm Through study completion, an average of 1 year
Secondary Demographic outcomes: Level of education choose category for the level of education Through study completion, an average of 1 year
Secondary Demographic outcomes: name the University For students only Through study completion, an average of 1 year
Secondary Demographic outcomes: name your department For students only Through study completion, an average of 1 year
Secondary Demographic outcomes: year of study For students only Through study completion, an average of 1 year
Secondary Demographic outcomes: Employment status choose category for the employment status and specify your scope of activities if any Through study completion, an average of 1 year
Secondary use of nicotine Fact and frequency of use of nicotine Through study completion, an average of 1 year
Secondary use of alcohol Fact and frequency of use of alcohol Through study completion, an average of 1 year
Secondary Medical history Presence of any chronic illnesses (specify the name) Through study completion, an average of 1 year
Secondary duration of complaints Question: how long do you experience multiple dreams Through study completion, an average of 1 year
Secondary Average duration of sleep hours Through study completion, an average of 1 year
Secondary dreams during daytime nap Presence of dreams during daytime nap (yes or no) Through study completion, an average of 1 year
Secondary Amount of dreams during the night specify number (0, 1, 2, 3 and more) Through study completion, an average of 1 year
Secondary discomfort after the night of active dreaming Presence of discomfort after the night of active dreaming in the morning or during the day Through study completion, an average of 1 year
Secondary triggers of active dreaming Were you able to identify a factor or event that triggered the appearance of multiple dreams? If yes, specify. Through study completion, an average of 1 year
Secondary Intensity of thought activity in dream range 1-5 Through study completion, an average of 1 year
Secondary Intensity of speech activity in dream range 1-5 Through study completion, an average of 1 year
Secondary Intensity of running in dream range 1-5 Through study completion, an average of 1 year
Secondary Intensity of walking in dream range 1-5 Through study completion, an average of 1 year
Secondary Intensity of monotonous physical movements in dream range 1-5 Through study completion, an average of 1 year
Secondary Intensity of flight in dream range 1-5 Through study completion, an average of 1 year
Secondary Intensity of swimming in dream range 1-5 Through study completion, an average of 1 year
Secondary Intensity of jumping in dream range 1-5 Through study completion, an average of 1 year
Secondary Intensity of trip by transport in dream range 1-5 Through study completion, an average of 1 year
Secondary recalling dreams upon awakening Question: After waking up, do you remember what you saw in the dream? with 3 options - I remember that I had a dream, but I don't remember what it was about
I remember what the dream was about
I remember all the details of the dream
Through study completion, an average of 1 year
Secondary characteristics of dream content Intensity of positive emotions (range 1-5) Through study completion, an average of 1 year
Secondary characteristics of dream content Intensity of negative emotions (range 1-5) Through study completion, an average of 1 year
Secondary Impression that your brain stays awake while you sleep range 1-5 Through study completion, an average of 1 year
Secondary Any peculiarities of your dream specify Through study completion, an average of 1 year
Secondary Awareness of a dream I don't realize I'm dreaming; I am aware that I am dreaming, but I have no control; Awareness of dreaming and controlling; I realize that I'm dreaming and I can change the plot Through study completion, an average of 1 year
Secondary Subjective symptoms in the morning after a night of active dreaming Presence and length of the symptome Having difficulty knowing whether something happened in the dream or in reality Through study completion, an average of 1 year
Secondary Subjective symptoms in the morning after a night of active dreaming Presence and length of the symptom the feeling you had in the dream persists during the wakefulness for more than a few seconds Through study completion, an average of 1 year
Secondary Subjective symptoms in the morning after a night of active dreaming Presence and length of the symptom Heart palpitations Through study completion, an average of 1 year
Secondary Subjective symptoms in the morning after a night of active dreaming Presence and length of the symptom Shortness of breath Through study completion, an average of 1 year
Secondary Subjective symptoms in the morning after a night of active dreaming Presence and length of the symptom Hyperhidrosis Through study completion, an average of 1 year
Secondary Subjective symptoms in the morning after a night of active dreaming Presence and length of the symptom feeling Cold Through study completion, an average of 1 year
Secondary Subjective symptoms in the morning after a night of active dreaming Presence and length of the symptom Fatigue Through study completion, an average of 1 year
Secondary Subjective symptoms in the morning after a night of active dreaming Presence and length of the symptom Bad mood Through study completion, an average of 1 year
Secondary Subjective symptoms in the morning after a night of active dreaming Presence and length of the symptom Muscle pain Through study completion, an average of 1 year
Secondary Subjective symptoms in the morning after a night of active dreaming Presence and length of the symptom Headache Through study completion, an average of 1 year
Secondary Subjective symptoms in the morning after a night of active dreaming Presence and length of the symptom Pain in chest Through study completion, an average of 1 year
Secondary Subjective symptoms in the morning after a night of active dreaming Presence and length of the symptom Balance disturbance Through study completion, an average of 1 year
Secondary Subjective symptoms in the morning after a night of active dreaming Presence and length of the symptom Loss of tactile sensitivity Through study completion, an average of 1 year
Secondary Subjective symptoms in the morning after a night of active dreaming Presence and length of the symptom Tingling/frowning sensation Through study completion, an average of 1 year
Secondary Subjective symptoms in the morning after a night of active dreaming Presence and length of the symptom Anxiety Through study completion, an average of 1 year
Secondary Subjective symptoms in the morning after a night of active dreaming Presence and length of the symptom Weakness Through study completion, an average of 1 year
Secondary Subjective symptoms in the morning after a night of active dreaming Presence and length of the symptom Nausea Through study completion, an average of 1 year
Secondary Subjective symptoms in the morning after a night of active dreaming Presence and length of the other symptoms, if any Through study completion, an average of 1 year
Secondary Use of medications Question about the use of medication, no or yes (specify the name) Through study completion, an average of 1 year
Secondary Dose of medications Question about the dose of medication, if any Through study completion, an average of 1 year
Secondary Frequency of medications Question about the frequency of medications use, if any Through study completion, an average of 1 year
Secondary awakenings during the night Number of awakenings during the night Through study completion, an average of 1 year
Secondary Frequency of nights with multiple dreams Number of nights per week Through study completion, an average of 1 year
Secondary Seasonal fluctuation of the multiple dreams During which season do the multiple dreams occur more often Through study completion, an average of 1 year
Secondary Family history of Excessive dream disorder Did any of your family members has the same complaints, if yes, specify Through study completion, an average of 1 year
Secondary Depression symptoms Beck Depression scale Through study completion, an average of 1 year
Secondary State anxiety symptoms State anxiety by Spielberger Anxiety Scale Through study completion, an average of 1 year
Secondary Trait anxiety symptoms Trait anxiety by Spielberger Anxiety Scale Through study completion, an average of 1 year
Secondary Shortened Sleep Questionnaire Validated questionnaire to evaluate insomniac complaints, parasomnias, use of medications, hypersomnias, sleep related breathe disorders Through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Terminated NCT04749992 - Biological Function of Dreaming in Dreaming and Non-Dreaming Patients With PCA Infarction